Moderna and Ross Stores Lead Stock Gainers on Wednesday
Moderna surges 8.9% after settling a $2.25 billion patent dispute with Arbutus and Genevant over lipid nanoparticle technology, eliminating future royalty obligations and litigation risks for its mRNA pipeline.
Moderna and Ross Stores Lead Stock Gainers on Wednesday
Moderna surges 8.9% after settling a $2.25 billion patent dispute with Arbutus and Genevant over lipid nanoparticle technology, eliminating future royalty obligations and litigation risks for its mRNA pipeline.